Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
984
mi
from 98109
Orange, CA
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1059
mi
from 98109
San Diego, CA
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1059
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
2726
mi
from 98109
North Miami, FL
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
2726
mi
from 98109
North Miami, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1956
mi
from 98109
Dayton, OH
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1956
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1677
mi
from 98109
Dallas, TX
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1677
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1065
mi
from 98109
Lemon Grove, CA
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1065
mi
from 98109
Lemon Grove, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
979
mi
from 98109
Long Beach, CA
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
979
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
874
mi
from 98109
Las Vegas, NV
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
874
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
2386
mi
from 98109
Marlton, NJ
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
2386
mi
from 98109
Marlton, NJ
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
5941
mi
from 98109
Burgas,
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
5941
mi
from 98109
Burgas,
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1639
mi
from 98109
Springdale, AR
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1639
mi
from 98109
Springdale, AR
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1721
mi
from 98109
Saint Louis, MO
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1721
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
2322
mi
from 98109
Washington,
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated:  12/31/1969
McLean Hospital
2478
mi
from 98109
Belmont, MA
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
McLean Hospital
2478
mi
from 98109
Belmont, MA
Click here to add this to my saved trials
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
2484
mi
from 98109
Charlestown, MA
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
2484
mi
from 98109
Charlestown, MA
Click here to add this to my saved trials
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Status: Enrolling
Updated:  12/31/1969
Segal Institute for Clinical Research 1201 North 37th Avenue
2722
mi
from 98109
Hollywood, FL
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Status: Enrolling
Updated: 12/31/1969
Segal Institute for Clinical Research 1201 North 37th Avenue
2722
mi
from 98109
Hollywood, FL
Click here to add this to my saved trials
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Status: Enrolling
Updated:  12/31/1969
Minneapolis VA Health Care System
1391
mi
from 98109
Minneapolis, MN
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
Status: Enrolling
Updated: 12/31/1969
Minneapolis VA Health Care System
1391
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1782
mi
from 98109
Little Rock, AR
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1677
mi
from 98109
Dallas, TX
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1677
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
982
mi
from 98109
Garden Grove, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
982
mi
from 98109
Garden Grove, CA
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1059
mi
from 98109
San Diego, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1059
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
2730
mi
from 98109
Miami, FL
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1956
mi
from 98109
Dayton, OH
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1956
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1639
mi
from 98109
Springdale, AR
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1639
mi
from 98109
Springdale, AR
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1065
mi
from 98109
Lemon Grove, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1065
mi
from 98109
Lemon Grove, CA
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
984
mi
from 98109
Orange, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
874
mi
from 98109
Las Vegas, NV
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
874
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
2386
mi
from 98109
Marlton, NJ
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
2386
mi
from 98109
Marlton, NJ
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
5941
mi
from 98109
Burgas,
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
5941
mi
from 98109
Burgas,
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1721
mi
from 98109
Saint Louis, MO
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1721
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational site
964
mi
from 98109
Culver City, CA
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational site
964
mi
from 98109
Culver City, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
982
mi
from 98109
Garden Grove, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
982
mi
from 98109
Garden Grove, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
955
mi
from 98109
Glendale, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
955
mi
from 98109
Glendale, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
976
mi
from 98109
Torrance, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
976
mi
from 98109
Torrance, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1782
mi
from 98109
Little Rock, AR
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1639
mi
from 98109
Springdale, AR
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1639
mi
from 98109
Springdale, AR
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
981
mi
from 98109
Anaheim, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
981
mi
from 98109
Anaheim, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
976
mi
from 98109
Cerritos, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
976
mi
from 98109
Cerritos, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational site
964
mi
from 98109
Culver City, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational site
964
mi
from 98109
Culver City, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
979
mi
from 98109
Long Beach, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
979
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1069
mi
from 98109
National City, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1069
mi
from 98109
National City, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
678
mi
from 98109
Oakland, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
678
mi
from 98109
Oakland, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1031
mi
from 98109
Oceanside, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1031
mi
from 98109
Oceanside, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
984
mi
from 98109
Orange, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
968
mi
from 98109
Pico Rivera, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
968
mi
from 98109
Pico Rivera, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
975
mi
from 98109
Redlands, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
975
mi
from 98109
Redlands, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1059
mi
from 98109
San Diego, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1059
mi
from 98109
San Diego, CA
Click here to add this to my saved trials